WCG Insights Home » Patient Engagement » Rare & Orphan Disease Endpoints: Challenges & Examples from Neurodevelopment
Benchmark your study enrollment versus competitorsGet Benchmark Data
Other content in this Stream
Solving the Problem of Clinical Research Enrollment
Six Practices of High Performing Clinical Research Sites
Learn what high-performing research sites have in common, and what makes sponsors return to them again and again.
Recruiting Patients & Time Management: Top Tips for Dealing with the Most Critical Resource in Research
Learn how to engage sites more effectively with the appropriate recruitment resources, use dedicated staff to manage recruitment efforts, and eliminate bottlenecks and expedite recruitment timelines.
Clinical Trial Recruitment Practices: The Evolution of Ethical Considerations
Subject Recruitment Materials: Understanding the Requirements for IRB Review
Often, the only way for potential research subjects to learn about a clinical trial is through recruitment materials. But what materials must you submit to the IRB for review?
eCOA: Keep it Simple, Exec Argues
CNS Drugs Take Longer to Develop, Win Approval
Clinical Trials and Social Media - Friends or Foes?
Rare Disease Case Study: Pediatric Sickle Cell Anemia
Our client, a Top 10 pharmaceutical company, needed to boost enrollment for their phase ll pediatric sickle cell anemia study.
Personalized Medicine Requires Personalized Measurement
Patient Engagement Services Overview
Patient Recruitment for Ophthalmology Study (Glaucoma and Retinal Disease)
A leading pharma company needed assistance to rescue their enrolling ophthalmology study. The sponsor was attempting to complete enrollment for a normative, glaucoma and retinal disease study.
Patient Recruitment for Multi-Protocol Global Program (Phase III Cardiovascular Disease)
Our customer needed support for a global, multi-protocol program which was behind with enrollment.
Looking Ahead in 2018: Insights into Clinical Research Trends from Our Experts
In this paper, WCG thought-leaders provide insights on what they anticipate in 2018 in clinical trial technology, regulatory changes, and scientific developments.
Placebo Response in Clinical Trials: Approaches to Mitigation
Industry trends show that a major contributor to trial failure is the increased rate of placebo response.Watch this webinar to learn how to increase the chances of trial success in an uncertain world.
Rare Disease Case Study: Familial Amyloidosis
Our client, a top-tier CRO, was faced with the challenge of enrolling for a non-interventional screening study in the familial amyloidotic cardiomyopathy (FAC) patient population.
Addressing Placebo Response
Suicidality Assessment in China
All training materials and consultation were provided in Mandarin. A custom patient-simulation video was created with a Mandarin-speaking clinician interviewing a Mandarin-speaking patient. Additional
Training Program for Japan